Descriptive analysis of postmarket surveillance data for hip implants.
Josep PaneKatia M C VerhammeIrene RebolloMiriam C J M SturkenboomPublished in: Pharmacoepidemiology and drug safety (2020)
The underlying data should meet high quality standards to generate more evidence and to ensure a timely signal generation. This case study shows that the completeness and quality of the MDRs can be improved. The authors propose the development of tools to ensure a more dynamic complaint data collection to contribute to this enhancement.